Publication: European Position Statement on Diagnosis, and Treatment of Meniere's Disease.
dc.contributor.author | Magnan, Jacques | |
dc.contributor.author | Özgirgin, O Nuri | |
dc.contributor.author | Trabalzini, Franco | |
dc.contributor.author | Lacour, Michel | |
dc.contributor.author | Escamez, Antonio Lopez | |
dc.contributor.author | Magnusson, Mans | |
dc.contributor.author | Güneri, Enis Alpin | |
dc.contributor.author | Guyot, Jean Philippe | |
dc.contributor.author | Nuti, Daniele | |
dc.contributor.author | Mandalà, Marco | |
dc.date.accessioned | 2023-01-25T10:22:37Z | |
dc.date.available | 2023-01-25T10:22:37Z | |
dc.date.issued | 2018 | |
dc.description.abstract | Meniere Disease keeps challenges in its diagnosis and treatment since was defined by Prosper Meniere at the beginning of 19th Century. Several classifications and definition were made until now and speculations still exist on its etiology. As the etiology remains speculative the treatment models remain in discussion also. The European Academy of Otology and Neurotology Vertigo Guidelines Study Group intended to work on the diagnosis and treatment of Meniere's disease and created the European Positional Statement Document also by resuming the consensus studies on it. The new techniques on diagnosis are emphasized as well as the treatment models for each stage of the disease are clarified by disregarding the dilemmas on its treatment. The conservative, noninvasive and invasive therapeutic models are highlighted. | |
dc.identifier.doi | 10.5152/iao.2018.140818 | |
dc.identifier.issn | 1308-7649 | |
dc.identifier.pmc | PMC6354459 | |
dc.identifier.pmid | 30256205 | |
dc.identifier.pubmedURL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354459/pdf | |
dc.identifier.unpaywallURL | https://doi.org/10.5152/iao.2018.140818 | |
dc.identifier.uri | http://hdl.handle.net/10668/13000 | |
dc.issue.number | 2 | |
dc.journal.title | The journal of international advanced otology | |
dc.journal.titleabbreviation | J Int Adv Otol | |
dc.language.iso | en | |
dc.organization | Hospital Universitario Virgen de las Nieves | |
dc.organization | Centro Pfizer-Universidad de Granada-Junta de Andalucía de Genómica e Investigación Oncológica-GENYO | |
dc.page.number | 317-321 | |
dc.pubmedtype | Journal Article | |
dc.pubmedtype | Review | |
dc.rights | Attribution-NonCommercial 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | |
dc.subject.mesh | Anti-Bacterial Agents | |
dc.subject.mesh | Betahistine | |
dc.subject.mesh | Consensus | |
dc.subject.mesh | Conservative Treatment | |
dc.subject.mesh | Denervation | |
dc.subject.mesh | Diuretics | |
dc.subject.mesh | Endolymphatic Sac | |
dc.subject.mesh | European Union | |
dc.subject.mesh | Gentamicins | |
dc.subject.mesh | Hearing Loss, Sensorineural | |
dc.subject.mesh | Histamine Agonists | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Injection, Intratympanic | |
dc.subject.mesh | Meniere Disease | |
dc.subject.mesh | Neurotology | |
dc.subject.mesh | Otolaryngology | |
dc.subject.mesh | Practice Guidelines as Topic | |
dc.subject.mesh | Steroids | |
dc.subject.mesh | Vestibular Evoked Myogenic Potentials | |
dc.subject.mesh | Vestibular Nerve | |
dc.subject.mesh | Vestibule, Labyrinth | |
dc.title | European Position Statement on Diagnosis, and Treatment of Meniere's Disease. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 14 | |
dspace.entity.type | Publication |